Full Length Research Paper
References
Ahlburg DA (2000). The Economic Impacts of Tuberculosis. In The STOP TB Initiative 2000 Series. Amsterdam: Word Health Organization; 32p. |
|
Ataguba JE (2011). Reassessing Catastrophic Health-Care Payments with a Nigerian Case Study. Health Economics. Policy. Law. 18. |
|
Barter DM, Agboola SO, Murray MB, and Bärnighausen T (2012). Tuberculosis and Poverty: The Contribution of Patient Costs in Sub-Saharan Africa-A Systematic Review BMC 12:980. |
|
Collins D, Beyene D, Tedla Y, Diro E, Mesfin H, Levin A (2013). Costs faced by multi-drug resistant tuberculosis patients during diagnosis and treatment. Report from a pilot study in Ethiopia. Cambridge, MA, USA: TB CARE I-Management Sciences for Health. |
|
Dim CC, and Dim NR (2013). Trends of Tuberculosis Prevalence and Treatment Outcome in an Under-resourced Setting: The Case of Enugu State, South East Nigeria. Nigerian Medical Journal 54:392-7 |
|
Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2007). Basic Types of Economic Evaluation. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York, P 24. |
|
Elender F, Bentham G, and Langford I (1998). Tuberculosis Mortality in England and Wales during 1982-1992: Its Association with Poverty, Ethnicity and AIDS. Social Science and Medicine 46(6):673-681. |
|
Fabricant SJ, Kamara CW, and Mills A (1999). Why The Poor Pay More: Household Curative Expenditures in Rural Sierra Leone. The International Journal of Health Planning and Management 14:179-199. |
|
Foster N, Vassal A, and Sinanovic E (2015). The Economic Burden of TB Diagnosis and Treatment in South Africa. Social Science and Medicine 130:42-50. |
|
Hansel NN, Wu AW, Chang B, Diette GB (2004). Quality of Life in Tuberculosis: Patient and Provider Perspectives. International Journal of Quality of Life Aspects of Treatment, Care Rehabilitation 13(3):639-652. |
|
Kemp JR, Mann G, Simwaka BN (2007). Can Malawi's poor afford free tuberculosis services. Patient and Household Costs Associated with a |
|
Tuberculosis Diagnosis in Lilongwe. Bulletin of the World Health Organization 85:580-585. |
|
Kumar V, Abbas AK, Fausto N, Mitchell RN (2007). Robbins Basic Pathology, 8th edition. Philadelphia, USA, Saunders Elsevier 39-42. |
|
Laokri S, Drabo ML, Weil O, Kafando B, Dembélé SM, and Dujardin B (2013).Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso. PLoS One 8(2)56752. |
|
Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC (2010).Tuberculosis Control and Elimination. 2010-50: Cure, Care, and Social Development. The Lancet 375(9728):1814-1829. |
|
Nigerian Medical Association (NMA) (2013). 27,000 Nigerians Die of Tuberculosis Yearly. 'Retrieved from' View. Accessed on 22 APRIL, 2014. |
|
Oxlade O, Murray M (2012). Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One 7:47533, |
|
Paton NI, Ng YM (2006). Body Composition Studies in Patients with Wasting Associated with Tuberculosis. Nutrition (Burbank, Los Angeles County, California) 22(3):245-251 |
|
Peter R, Donald B, Chan M, and Paul D (2009). The global burden of tuberculosis-combating drug resistance in difficult times. The New England Journal of Medicine 360:2393-2395. |
|
Rundi C (2010). Understanding Tuberculosis: Perspective and Experiences of the people of Sabah, East Malaysia. Journal of Health, Population and Nutrition 28(2):114-123. |
|
Russell S (2004). The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acqiured immunodeficiency syndrome. The American Journal of Tropical Medicine and Hygiene 71(4):147-155. |
|
Sagbakken M, Frich J, and Bjune G (2008). Barriers and Enablers in the Management of Tuberculosis Treatment in Addis Ababa, Ethiopia: A Qualitative Study. BMC Public Health 8:11. |
|
Sanou A, Dembele M, Theobald S, Macq J (2004). Access and Adhering to Tuberculosis Treatment: Barriers Faced by Patients and Communities in Burkina Faso. International Journal of Tuberculosis and Lung Disease 8:1479-1483. |
|
Tony TO, Odunayo OO, Victor A A (2015). A Retrospective Study of the Incidence of Pulmonary Tuberculosis and Human Immunodeficiency Virus Co-Infection among Patients Attending National Tuberculosis and Leprosy Control Programme, Owo Centre. Pamj 20 345. |
|
Ukwaja KN, Alobu I, lgwenyi C, Hopewell PC (2013). The high cost of free tuberculosis services: Patient and household costs associated with tuberculosis care in Ebonyi tate, Nigeria. |
|
Ukwaja KN, Modebe O, Igwenyi C, Alobu I (2012). The Economic Burden of Tuberculosis Care for Patients and Households in Africa: A Systematic Review. International Journal of Tuberculosis and Lung Disease 16:733-739. |
|
Umar N, Abubakar I, Fordham R, Bachmann M (2012). Direct Costs of Pulmonary Tuberculosis among Patients Receiving Treatment in Bauchi State, Nigeria. International Journal of Tuberculosis and Lung Disease 16:835-840. |
|
Whitehead M, Dahlgren G, Evans T (2001). Equity and health sector reforms: can low-income countries escape the medical poverty trap? Lancet 358:833-836. |
|
World Health Organization (WHO) (2005). Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report No. 3. Prevalence and Trends. WHO/HTM/TB/2004.343. Geneva, Switzer-land. |
|
World Health Organization (WHO) (2009). Epidemiology. Global tuberculosis control: epidemiology, strategy, financing mates of TB burden.6-33. PubMed | Google Scholar. |
|
World Health Organization (WHO) (2010). Tuberculosis. In: Raviglione Mario C., editor. The Essentials. Fourth Edition. Geneva Switzerland: World Health Organization. |
|
World Health Organization (WHO) (2011). WHO report: Global tuberculosis control. Geneva, Switzerland: WHO; WHO/HTM/TB/2011.16. |
|
World Health Organization (WHO) (2012). Group of risk. WHO global tuberculosis report. |
|
World Health Organization (WHO) (2013a). WHO Country Cooperation Strategy 2012-2015. Ethiopia: WHO Regional Office for Africa, Republic of Congo. |
|
World Health Organization (WHO) (2013b). Global Tuberculosis Control. WHO Report 2013, Geneva. |
|
Wingfield V, Boccia V, Tovar V, Gavino A, Zevallos K, Montoya R, Lönnroth K, Evans C (2014). Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. Plos Medicine 11(7):e1001675 |
|
Zumla A, Mario R, Richard H, Fordham C (2013). Tuberculosis. The New England Journal of Medicine 368:745-55. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0